Managing Latent TB for the I/T/U Provider | October 21, 2021
Date of Presentation: October 21, 2021
Type: Past Presentation
Program: Infectious Disease ECHO Program
In this series of presentations, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, provides a clinical update on emerging COVID-19 topics. Then, Dr. Marcos Burgos, associate professor and Medical Director of the Tuberculosis Program for the New Mexico Department of Health, discusses best practices for identifying and managing latent TB followed by practical case discussions from Indian Health Service, Tribal and Urban Indian clinicians.
Dr. Jonathan Iralu, MD, FACP; Dr. Marcos Burgos, MD
Jonathan Iralu, MD, FACP, is the Indian Health Service Chief Clinical Consultant for Infectious Diseases. He has a special interest in HIV, tuberculosis and sexually transmitted disease care in rural communities. His research has focused on undifferentiated febrile illness in the American Southwest and on rural HIV care delivery. Dr. Iralu has worked at the Gallup Indian Medical Center since 1994 and is an instructor at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital Division of Global Health Equity in Boston, Massachusetts.
Marcos Burgos, MD, is an associate professor and Medical Director of the Tuberculosis Program for the New Mexico Department of Health. He is board certified in Internal Medicine and Infectious Diseases. Dr. Burgos’ research focuses in international health, tuberculosis control programs, drug-resistant tuberculosis and molecular epidemiology. He has published original research papers in these areas. In his role as Medical Director of the tuberculosis program, he supervises the care of patients and consults with medical providers to oversee treatment of tuberculosis in New Mexico.
Date added: October 21, 2021